HIV and highly active antiretroviral therapy: dyslipidemia, metabolic aberrations, and cardiovascular risk.

Wei Zou; Lars Berglund

doi:10.1111/j.1520-037X.2007.03071.x

HIV and highly active antiretroviral therapy: dyslipidemia, metabolic aberrations, and cardiovascular risk.

Wei Zou, Lars Berglund

Endocrinology, Diabetes, and Metabolism

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Original language	English (US)
Journal	Preventive Cardiology
Volume	10
Issue number	2
DOIs	https://doi.org/10.1111/j.1520-037X.2007.03071.x
State	Published - Mar 2007

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Public Health, Environmental and Occupational Health

Access to Document

10.1111/j.1520-037X.2007.03071.x

Cite this

@article{3f0fe9b05fb64c3684adaf34cf0b26be,

title = "HIV and highly active antiretroviral therapy: dyslipidemia, metabolic aberrations, and cardiovascular risk.",

author = "Wei Zou and Lars Berglund",

year = "2007",

month = mar,

doi = "10.1111/j.1520-037X.2007.03071.x",

language = "English (US)",

volume = "10",

journal = "Preventive Cardiology",

issn = "1520-037X",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - HIV and highly active antiretroviral therapy

T2 - dyslipidemia, metabolic aberrations, and cardiovascular risk.

AU - Zou, Wei

AU - Berglund, Lars

PY - 2007/3

Y1 - 2007/3

UR - http://www.scopus.com/inward/record.url?scp=34447514368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447514368&partnerID=8YFLogxK

U2 - 10.1111/j.1520-037X.2007.03071.x

DO - 10.1111/j.1520-037X.2007.03071.x

M3 - Article

C2 - 17392622

AN - SCOPUS:34447514368

VL - 10

JO - Preventive Cardiology

JF - Preventive Cardiology

SN - 1520-037X

IS - 2

ER -

HIV and highly active antiretroviral therapy: dyslipidemia, metabolic aberrations, and cardiovascular risk.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this